21Lodgement of contact preference—prescribed explanatory material

21 Lodgement of contact preference—prescribed explanatory material

For the purposes of section 63J(3) of the Act, the following information is prescribed explanatory material—

(c) information about possible consequences for the person born as a result of a donor treatment procedure or, if the person is a child, the person's parent or guardian if a contact preference is lodged;

(d) information about possible consequences for the person born as a result of a donor treatment procedure or, if the person is a child, the person's parent or guardian if a contact preference is not lodged;

(e) information about the requirements of Part 6 of the Act in relation to the disclosure of identifying information from the Central Register;

(f) information about mental health support and intervention services that can provide crisis support and any other support services that might be relevant to the person born as a result of a donor treatment procedure or, if the person is a child, the person's parent or guardian;

(g) information about counselling services available to the person born as a result of a donor treatment procedure or, if the person is a child, the person's parent or guardian;

(h) information about the issues which may arise for the person born as a result of a donor treatment procedure or, if the person is a child, the person's parent or guardian if the person or the person's parent or guardian is contacted by another person following the disclosure of identifying information from the Central Register;

(i) information about the Donor Conception Registrar's reasons for providing the explanatory material to the person born as a result of a donor treatment procedure or, if the person is a child, the person's parent or guardian;

(j) information about the benefits to the person born as a result of a donor treatment procedure or, if the person is a child, the person's parent or guardian of considering the explanatory material;

(k) information about how to approach discussions about genetic and medical issues and possible outcomes of those discussions;

(l) if the person born as a result of a donor treatment procedure is a child, information about—

(iii) the significance to the child of a biological connection with the donor and the benefits of early disclosure and early connection with any donor siblings; and

(vi) any issues that may arise for the child if contact is made with any donor siblings who are raised in different families.

Reg. 21A inserted by S.R. No. 141/2024 reg. 17.

21A Amending contact preferences in relation to persons born as a result of a donor treatment procedure—prescribed explanatory material